FB2025_01 , released February 20, 2025
Allele: Dmel\MED9GD8665
Open Close
General Information
Symbol
Dmel\MED9GD8665
Species
D. melanogaster
Name
FlyBase ID
FBal0218954
Feature type
allele
Associated gene
Dmel\MED9
Associated Insertion(s)
Carried in Construct
P{GD8665}
Key Links
Genomic Maps

Transgenic product class
RNAi_reagent
(Dickson et al., 2007.7.18)
Mutagen
Nature of the Allele
Transgenic product class
RNAi_reagent
(Dickson et al., 2007.7.18)
Mutagen
in vitro construct
(Dickson et al., 2007.7.18)
Progenitor genotype
Carried in construct
P{GD8665}
Cytology
Description

UASt regulatory sequences drive expression of an inverted repeat.

(Dickson et al., 2007.7.18)
Allele components
Component
Use(s)
Regulatory region(s)
UASt
Encoded product / tool
dsRNA-GD8665
Mutations Mapped to the Genome
Curation Data
Type
Location
Additional Notes
References
Variant Molecular Consequences
Associated Sequence Data
DDBJ / EMBL / GenBank
DNA sequence
Protein sequence
 
UniProtKB/Swiss-Prot
    UniProtKB/TrEMBL
      Expression Data
      Reporter Expression
      Additional Information
      Statement
      Reference
       
      Marker for
      Reflects expression of
      Reporter construct used in assay
      Human Disease Associations
      Disease Ontology (DO) Annotations
      Models Based on Experimental Evidence ( 0 )
      Disease
      Evidence
      References
      Modifiers Based on Experimental Evidence ( 0 )
      Disease
      Interaction
      References
      Comments on Models/Modifiers Based on Experimental Evidence ( 0 )
       
      Disease-implicated variant(s)
       
      Phenotypic Data
      Phenotypic Class
      Phenotype Manifest In
      Detailed Description
      Statement
      Reference

      Expression of MED9GD8665 under the control of Scer\GAL4bam.T:Hsim\VP16 (in combination with a Dicer-2 transgene to enhance RNAi efficiency) results in partial meiotic arrest in spermatocytes.

      (Lu and Fuller, 2015)

      Expression of MED9GD8665 under the control of Scer\GAL4elav.PLu (in combination with a Dicer-2 transgene to enhance RNAi efficiency) results in a significant decrease in virgin female receptivity when mutant females are paired with single wild type males, but not when mutant females are paired with 2 wild type males, as compared to controls.

      (Bussell et al., 2014)

      Adults expressing MED9GD8665 under the control of the cardioblast-specific Scer\GAL4tin.CΔ4 driver show significantly reduced survival on day 6 after a shift to 29[o]C compared to control flies.

      (Neely et al., 2010)

      Adults expressing MED9GD8665 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) show significantly reduced avoidance of noxious temperature (46[o]C) compared to control flies.

      (Neely et al., 2010)

      Depending on the insertion line used, expression under the control of Scer\GAL4Mef2.PR can result in adult/pharate lethality or late pupal lethality.

      (Schnorrer et al., 2010)
      External Data
      Interactions
      Show genetic interaction network for Enhancers & Suppressors
      Phenotypic Class
      Phenotype Manifest In
      Additional Comments
      Genetic Interactions
      Statement
      Reference
      Xenogenetic Interactions
      Statement
      Reference
      Complementation and Rescue Data
      Comments
      Images (0)
      Mutant
      Wild-type
      Stocks (1)
      Notes on Origin
      Discoverer
      External Crossreferences and Linkouts ( 0 )
      Synonyms and Secondary IDs (2)
      Reported As
      Symbol Synonym
      CG42517GD8665
      MED9GD8665
      Name Synonyms
      Secondary FlyBase IDs
      • FBal0207566
      • FBal0218735
      References (8)